Post by
JoeRoganBNN on Oct 31, 2017 8:27am
DIN# Key to Large Growth.
People, let’s all agree the main catalyst for tetra’s short to medium term growth is the issuance of PrinceptsRx. If sales are good with Aphria and results are shown to be effective in patients, the stock will jump like never before. I’m talking New 52-week highs over
night. Peoplr who try and short this stock will lose out at some point. Based on what I’m seeing for tier 2/3 data, those selling at a loss are being gobbled up.
Make no mistake, lots of money is waiting on the sidelines to buy out those who can’t stomach volatility. Anyone who’s ever bought bio tech companies are aware that it takes time to come to fruition. I’ve been around long enough to realize it. You need to believe in the company and its goals, otherwise what are you doing here...I do know that studies have been conducted in the past (with lower CBD and THC level marijuana) that has reduced pain in sufferers from 7/10 to 5.5/10 on average. a modest but significant improvement. However, today’s levels are double that and I can only assume the same test would result in sufferers having even less pain or discomfort. These trials will show their benefit. If this were the case then there is nothing to fear, as it’s a waiting game.
Comment by
Newbienewf on Oct 31, 2017 8:36am
any guess to when a possible din could take place?
Comment by
JoeRoganBNN on Oct 31, 2017 8:39am
It’s on the website, https://tetrabiopharma.com/home/default.aspx i believe it’s late 2019 and commercialization by 2020. Subsequently, if results are good you’ll see the benefit well in advance.